about
Pharmacogenetics and pharmacogenomicsPrediction of cytochrome P450 isoform responsible for metabolizing a drug moleculeChallenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewalMolecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugsA systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapyDetection of CYP2C19 Genetic Variants in Malaysian Orang Asli from Massively Parallel Sequencing DataPhase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses.Abacavir/lamivudine combination in the treatment of HIV: a review.The challenge of integrating genetic medicine into primary care.Medical genetics: 1. Clinical teratology in the age of genomics.Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening dataPolymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.Metoclopramide in the treatment of diabetic gastroparesis.The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.Prediction of Cytochrome P450 Profiles of Environmental Chemicals with QSAR Models Built from Drug-like Molecules.The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.Genetic research with stored biological materials: ethics and practice.Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.Host-environment medicine: a primary care model for the age of genomics.The hunt for new genes and polymorphisms that can control the response to drugs.Pharmacogenomics: the future of drug therapy.Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.Genomics in obstetrics and gynaecology.Pharmacogenetics and the print media: what is the public told?Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients.Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial.Pharmacogenetics approach to therapeutics.Validation of tacrolimus equation to predict troughs using genetic and clinical factors.Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.Avoiding adverse drug reactions by pharmacogenetic testing: a systematic review of the economic evidence in the case of TPMT and AZA-induced side effects.Use of plasmid-derived external quality control samples in pharmacogenetic testing.Classical twin design in modern pharmacogenomics studies.Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.Factors affecting the anthelmintic efficacy of papaya latex in vivo: host sex and intensity of infection.Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer.Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges.
P2860
Q24564983-C80B68A4-3F28-4D17-B759-2B6804AB6F6DQ24599733-380D577B-741C-46F4-AFCA-AC2239FA3105Q24670636-46E5CDBB-5FB6-4E74-901C-E9E544941DAAQ24683013-2B4A0F5E-731C-47F8-8BE0-0129FE9B7624Q28533992-61F5B0BB-0763-4E6F-8EB4-46E9990A8366Q28553076-0B7DC1BA-FD1E-4CC3-B554-1B66BDE093A4Q33404493-CA06591B-2053-4F37-AA12-A9E4E3634AD5Q33715435-25E69022-8296-4DB8-90CB-5FDB72728BF2Q33805196-109EB394-EE66-40F2-BB4F-47059B8E2DA3Q33895431-FF27C709-BD20-4E36-8869-DD895EDFA19EQ34014895-84FD9520-8012-47AE-A85C-5E77B12C451AQ34331552-74B24312-8EFB-43AB-A7EE-708ABCCF0474Q34447018-AFCEE2F3-03AE-4CBE-9B5D-EAC0A4479A71Q34521600-C2F48905-2426-40B1-96B4-6448F4D35609Q34537662-582734F8-A2EC-49DA-9E30-D6B49B055AEFQ34608018-02198726-CA7F-4768-BE36-BFE22E0BCFA6Q34612112-20218E02-F1A3-4280-BF3B-02246B16F442Q34643365-98374554-4498-4C42-9F88-AEC7BC3883A2Q34697234-5A221060-88A2-493D-9068-8B24E34238CBQ34741165-3774BB25-3359-4413-A82F-62DF996EBE7BQ34837113-194C18AE-4824-4EA0-8078-BFE8135AFD07Q34952587-B130E8B7-06B3-42B1-95C4-450076200663Q35016337-0107CD49-DE26-4BBB-864F-BBB5DCD20BD7Q35625106-3BF9DAAD-8A40-4F4C-AEC9-F97C8BBD0AD4Q35625803-8308651B-6983-4DA2-B3E3-697D01441318Q35793287-3CED227C-E3D3-4876-9AE7-327CA6FB9BA9Q35812542-49320650-F41E-4562-A8B6-A1EDF0AE8435Q35876954-C4F37E52-B8B9-43FE-A88E-7B3F0C48F3F3Q36144114-D7EC8F90-1A93-4D8A-B2A6-B8345D2C21CAQ36478845-1528F902-4C9D-4CB5-BA6A-3ED03D682387Q36630077-94ABE7DD-AF1C-4EBE-B792-F0175A1FB6E1Q37205951-67B3E2B2-F7EA-4799-84F6-4AFE710440B4Q37207401-1627C01D-4FF3-406E-A1C0-3A503095BA2BQ37264536-60D4AF25-C29A-403E-A8BD-CAA79D6B09E0Q37688053-3EE49C13-99E8-471D-94FA-E71F981DB3B1Q38030051-BA30DFAF-4C60-4A6D-A9AF-B59A2926C00DQ39020159-F0AC68CE-8F8B-44ED-A25E-3F428B8ABD7FQ39065445-434F503A-FE98-4667-83D1-1A722A32DAE9Q39334234-8D0E62CF-D952-44DB-9D40-2030953620AEQ40565875-1BA94B80-274D-48F4-A407-60C439D89734
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Science, medicine, and the future: Pharmacogenetics.
@ast
Science, medicine, and the future: Pharmacogenetics.
@en
type
label
Science, medicine, and the future: Pharmacogenetics.
@ast
Science, medicine, and the future: Pharmacogenetics.
@en
prefLabel
Science, medicine, and the future: Pharmacogenetics.
@ast
Science, medicine, and the future: Pharmacogenetics.
@en
P2860
P356
P1433
P1476
Science, medicine, and the future: Pharmacogenetics.
@en
P2093
P2860
P304
P356
10.1136/BMJ.320.7240.987
P407
P577
2000-04-01T00:00:00Z